Home / Lincomycin / United States
US ATC J01FF02 · updated 2 Nov 2026
Lincomycin shortage in United States
Is there a Lincomycin shortage in United States?
Yes. As of 2 Nov 2026, 3 Lincomycin products are reported short in United States, the first since 25 Feb 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Lincocin, Injection, 2 mL multiple dose vial (NDC 0009-0104-04) discontinuation | Pfizer Inc. | 25 Feb 2026 | not given | Not stated |
| US | Lincomycin Hydrochloride, Injection, 600 mg/2 mL vial x 10 count (NDC 39822-0350-2) discontinuation | XGen Pharmaceuticals DJB, Inc. | 26 Mar 2026 | not given | Not stated |
| US | Lincomycin Hydrochloride, Injection, 3 grams/10 mL vial x 10 count (NDC 39822-0355-6) discontinuation | XGen Pharmaceuticals DJB, Inc. | 26 Mar 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).